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ABSTRACT
In this report the genomic characterization of the human excision
repair gene ERCC-1 is presented. The gene consists of 10 exons
spread over approximately 15 kb. By means of a transfection assay
the ERCC-1 promoter was confined to a region of + 170 bp upstream
of the transcriptional start site. Classical promoter elements
like CAAT, TATA and GC-boxes are absent from this region.
Furthermore, ERCC-1 transcription is not UV-inducible. A possible
explanation is provided for the previously reported alternative
splicing of exon VIII. Analysis of ERCC-1 cDNA clones revealed
the occurrence of differential polyadenylation which gives ERCC-1
transcripts of 3.4 and 3.8 kb in addition to the major 1.1 kb
mRNA. Apparent evolutionary conservation of differential
polyadenylation of ERCC-1 transcripts suggests a possible role
for this mode of RNA processing in the ERCC-1 repair function.
INTRODUCTION
In order to cope with DNA-lesions induced by mutagenic and
carcinogenic agents, living organisms have developed a variety of
DNA repair systems. One of the most important and best studied
repair processes is the excision repair pathway (see 1 for a
review). In Escherichia coli this system constitutes part of the
damage inducible SOS-response. Lesions causing a relatively
strong deformation of the normal helix structure (such as bulky
adducts or ultraviolet light (UV) induced pyrimidine dimers) are
recognized and removed by the concerted action of at least 4
excision repair proteins: uvr A,B,C and D (2). In yeast, mutant
analysis and gene cloning have demonstrated the existance of more
than 10 genetic loci implicated in excision repair (1). In higher
eukaryotes cell hybridization experiments have revealed the
presence of at least 9 complementation groups in cells from
excision deficient xeroderma pigmentosum patients (3,4) and of at
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least 5 groups in laboratory induced CHO repair mutant cells
(5,6). This extensive genetic heterogeneity suggests a
considerable biochemical complexity underlying the excision
repair pathway. However, the mechanism of this system in
eukaryotes is poorly understood.
We have recently cloned the first human repair gene, desig-
nated ERCC-1, that corrects the excision defect in CHO mutants of
complementation group 2 (7). The major ERCC-1 mRNA is 1.1 kb and
specifies a protein of 32.5 kD. Evidence was obtained for the
occurrence of alternative splicing yielding in addition a
transcript of 1.0 kb, lacking a 72 bp coding exon (8). However,
only the cDNA corresponding to the 1.1 kb mRNA, inserted in a
mammalian expression vector was able to correct the repair defect
in CHO mutants of group 2 (8). At the amino acid level a
significant homology was found with the yeast repair protein
RAD10 and parts of the E.coli uvrA and C gene products (8,9,10)
indicating strong evolutionary conservation of DNA repair
systems.
In this report we present the genomic organization of the
human ERCC-1 gene. We have identified the ERCC-1 promoter region
and provide evidence that the ERCC-1 mRNA is subject to differen-
tial polyadenylation during processing.
MATERIALS AND METHODS
Cell culture and transfections
UV-sensitive Chinese hamster ovary (CHO) cell line 43-3B
(11) and HeLa cells were grown in DMEM/F10+ (1:1) medium supple-
mented with 10% fetal calf serum and antibiotics (penicillin, 100
U/ml and streptomycin 0.1 mg/ml). ERCC-1 DNA constructs were
cotransfected with 0.5 - 3.0 Ug pSV3gptH to 43-3B cells as
described previously (8). After 10-14 days of selection with
mitomycin-C (MM-C) and mycophenolic acid resistant clones were
fixed and counted.
Identification of intron-exon borders
Using general procedures (12) all BglII fragments of
cosmid43-34 that hybridized to 32-labeled ERCC-1 cDNA probes were
subcloned in pUC-vectors. Hybridizing parts of these clones were
9196
Nucleic Acids Research
sequenced by the chemical degradation method of Maxam and Gilbert
(13).
Isolation of cDNAs
A human cDNA expression library made of poly(A)+ RNA from a
SV40 transformed fibroblast cell line was kindly provided by Dr.
H. Okayama and screened with a 1.05 kb PvuII fragment of the 3'
region of ERCC-1 (8).
Plasmid construction of the ERCC-1 romoter
The genomic 3.7 kb BglII fragment Bg3-Bg4 of cosmid43-34 (7)
was subcloned in pUC9 yielding p56-4. The ERCC-1 cDNA clone pcDE
has been described previously (8). The plasmids pROM-i and
pUCPROMH-1 containing the putative ERCC-1 promoter region linked
to the ERCC-1 cDNA and pERCC-SVP were constructed as follows:
pcDE was cleaved with HindIII, treated with Klenow enzyme, and
further digested with StuI which removes the SV40 promoter region
(HindIII-StuI) and an ERCC-1 StuI fragment. The resulting blunt
ended vector part of pcDE was ligated to this StuI fragment
yielding the promoterless construct pERCC-SVP. The pROM-1
construct was obtained by the consecutive cloning of a 1.3 kb
genomic PvuII-StuI fragment of 56-4 harboring the 5' half of exon
1 at its 3' end and the ERCC-1 StuI fragment in the HindIII
(Klenow)-StuI digested pcDE vector. A 1.3 kb Klenow treated
HinfI-BamHI fragment of pROM-i carrying the complete ERCC-1 cDNA
and 170 bp of 5' genomic DNA was ligated to HindII linearized
pUC18 resulting in pUCPROMH-1. Plasmid pROM-2 is similar to
pROM-i but has the ERCC-1 StuI fragment in the anti-sense orien-
tation.
Sl-mapping was performed as described by Grosveld et al.
(14). A uniformly 32P-labeled single stranded probe was synthe-
sized from M13-templates using the method of Burke (15) and an-
nealed with poly(A)+RNA (10 Ug) of K562 cells. After treatment
with nuclease Si the protected fragments were loaded on 6%
polyacrylamide sequence gels next to a sequence ladder as
molecular weight marker.
Northern blotting
Total RNA was prepared from cell cultures and isolated
nuclei as described by Auffray and Rougeon (16). The mRNA
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fraction was purified by two passages over oligo dT cellulose.
For Northern blot analysis poly(A)+ RNA (+ 20 ig) was size
fractionated by electrophoresis through 1% agarose/formaldehyde
gels, transferred to nitrocellulose, and hybridized to 32p_
labeled nick-translated probes.
HeLa cells were grown to near confluency on 15 cm Petri
dishes and irradiated with 254 nm TN (0.6 J/m2). Subsequently the
cells were rinsed with PBS and incubated with medium. After
several time intervals HeLa cells of 6 Petri dishes were
harvested by polishman and poly(A)+ RNA was isolated.
RESULTS
Gene Structure
Cosmid43-34, harboring the human ERCC-1 gene, was isolated
from a cosmid library of a repair proficient CHO 43-3B transfor-
mant (7). The size of the ERCC-1 gene and its location on cosmid
43-34 (cos43-34) was determined in 3 ways: i. By transfection of
restriction enzyme digested cos43-34 DNA to 43-3B cells to test
for intactness of the gene (7). ii. By subcloning of Sau3A
fragments of cos43-34 in EMBL-3 and screening for recombinant
phages carrying a functional gene (8). iii. By Southern blot
analysis of independent genomic 43-3B transformants for the
presence or absence of specific probes from the ERCC-1 flanking
regions (unpublished results). From these results it appeared
that ERCC-1 covered a region of 15 kb. A detailed physical map of
the deduced ERCC-1 region on cos43-34 is presented in Figure 1A.
To determine the structural organization of the gene all BglII
fragments in this region were subcloned in pUC-vectors and
hybridized with 32P-labeled probes of ERCC-1 cDNA clone pcDE (8).
Subsequently, appropriate hybridizing fragments were further
subcloned to sequence all exons and intron-exon junctions. The
sequence strategy, deduced transcriptional orientation and the
genomic organization of ERCC-1 are depicted in Figure 1B. The
human ERCC-1 gene appears to consist of 10 exons ranging in size
between 60 and 216 bp, spread over a region of 15 kb. The
nucleotide sequence of the exons was completely in accordance
with the previously reported ERCC-1 cDNA sequence (8). As shown
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Figure 1. Genomic organization of ERCC-1.
Detailed physical map (A) and intron-exon structure (B) of the
human excision repair gene ERCC-1. Arrow heads (in A) define
regions for which not all restriction enzyme cutting sites have
been mapped. Transcriptional orientation is indicated by the
large arrow. Exons (depicted as boxes) are indicated by Roman
numbers. The sequence strategy to determine intron-exon junctions
is indicated by small arrows. Filled boxes represent coding
sequences beginning with the indicated ATG. The differentially
spliced exon VIII is shown as a shaded box. Abbreviations: Ps
PstI; T : TaqI; S : SmaI; K : KpnI; Bg : BglII; Pv : PvuII.
in Figure 2, the sequences around the intron-exon borders are
consistent with the consensus donor and acceptor splicing signals
(17) The much less conserved sequence PyNPyTPuAPy which is
involved in branchpoint formation during the splicing process
(18,19) could tentatively be identified in most introns at the
appropriate distance (20 to 40 nucleotides) proximal to the
splice acceptor sites (Figure 2, see also Discussion).
The ERCC-l promoter region
The nucleotide sequence upstream from the first ERCC-1 exon
is shown in Figure 3. A perfect alignment of 142 bp with the 5'
terminus of the previously reported cDNA sequence (8) was found.
The precise start site of the ERCC-1 mRNA was determined by
nuclease Si analysis as demonstrated in Figure 4. A 2.0 kb
genomic fragment spanning from the PstI site in exon I (position
60 in cDNA clone pcDE, (8)) to an upstream BglII site was
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I NTRON
SPLICE ACCEPTOR
TGAGAACGTAGACCCCAGTGG
CTCACTCGCTCCTGGCACCTTCCCTTTCAG
CTCAGATGCCTCGCTCACCCCAACCA
GCCCCTGCAAACTCCCTTTTCTCCCCACAG
AT
ITATGGCTTCTGCCCTTCGTCCCTCCCCAG
CTTTGGGGGTCTTGAAGAGACTGAGAC
CTCTCAACTCCCGCTCCCAGCCCCCACCAG
GCTAATTTTTGTAATTCATGGCTTCT
AGGGTTTCTAATTCTGATTTTCTCCTCCAG
AATCTGATACCTCACC
TCCCGGCTGCCCTGTATCCTGTTATCCCAG
GCTCAGTCTTGCTGGCCTTTCTTCT
CCGACACACTCCTGCCTCCACCCTTTCCAG
GGACAGGGGAGGCTTTTGTGCTCAA
CTGCCTCGACCCCTCGCTTTCACCTTTCAG
CCAGAAAACAGCTCCTTTAATGCT
GGTTCCTCATTTTTTTCTCCCTCCATCCAG
EXON
GCTCCAG35
ALA LYs
GCC AAG
108
ARG GLY
AGG GGC
143
R LEU
C CTC
176
LYs AsP
AAA GAT
202
R PRO
c ccc
235
VAL THR
GTG ACT
259
SER LEU
TCT CTG
282
ALA ARG
GCC CGG
I (153) ACCACAG
34
GLY VAL
II (112) GGA GTG107
ARG GLN
III (216) CGG CAG
142
LEU SE
IV (104) CTC AG
175
Asp VAL
V (100) GAT GTG
201
TRP SE
VI (77) TGG AG
234
SER ARG
VII (100) TCC CGG
258
PHE GLY
VIII (72) TTT GGA
281
GLN Lys
IX (60) CAG AAA
X (112)
INTRON
SPLICE DONOR
GT GCGGGAGGCG
GT AGGACAA
GT GAGGAGGGAG
GT GAGCTCTGC
GT AAGCAGGGGG
GT GAGATGAGGG
GT GAGGCCACC
(0.3)
(1.9)
(0.7)
(1.2)
(2.3)
(1.8)
(0.9)
GT AAGGAATGGCT (0.2)
GT AAGAGCTCT (4.1)
3' POLY A TAIL
Figure 2. Structural details of the ERCC-1 intron-exon
organization. The nucleotide sequence of each intron-exon
junction is shown. Vertical lines represent intron-exon borders.
Splice acceptor and donor sequences are in accordance with
reported consensus sequence (C)nNCAG/G and AAG/GTA respectively
(17). The corresponding amino acids at the beginning and end of
each exon are shown in the three letter code and numbered as
reported previously (8). Exon numbering is as used in Fig. 1. The
size of each intron and exon (respectively kb and bp) is given in
parentheses. The length of exon I is based on the results
presented in Fig. 3 and 4. Heptamers which display the best match
with the splicing branchpoint consensus sequence PyNPyTPuAPy are
underlined.
subcloned in M13-mp8. Homogeneously 32P-labeled single stranded
DNA of this fragment was annealed to poly(A)+ RNA of K562 cells
and treated with nuclease Sl. Figure 4 shows a protected band of
73-75 bp. We conclude from this result that the transcription
most likely initiates at the A residues indicated in Figure 3
since these are generally preferred as 'capping'-site (17). From
these results it appears that cDNA clone pcDE is almost complete
(lacking only 9-11 bp at the 5' end, Figure 4) and consequently,
that exon 1 has a size of 151-153 bp. The ERCC-1 5' flanking
sequence is lacking the TATA and CAAT promoter signals. However
at position -100 a sequence with a low level of homology with the
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5' AACCGTAAGCTCCGG.GAGGACAACACGGGGC
-400
TGTCGTTGGTCACTGCTGTGTCACCAGCACGGACTCGCACAGGACCGGGAAGAGAGGAAG
-380 -360 -340
CGCGTGGGGGGAATAGGTGTGGAATAATGAATGMTGAGGAAACTGAAGCCAAGTCAAT
-320 -300 -280
GTCTGAGTTGGATTCAAACTTAAGTCTCTCCTTACTGAGAGGAG.GGACCAAGTTGGATCG
-260 -240 -220
CCTG.CGATCTGTTCTCCACTGMG.CCCTGCCAAGATTCTGGGCACACAGGMGCGCTCAGT
-200 -180 HINFI -160
AAGG.GCTTTGAAACTTAACAGTTTGGGAGCCAGATCCTCAGGCCACATCTCTC1TCIt
-140 -120 -100
ACGACGGT4GAAC.CATAGAGAGTTGTACAGAGATCGCCMGCTCT
-80 -60 -40
ItICIjTCTCCTGGG.GAGCGGGGCCAGAGAGGCCGGAAGTGCTGCGAGCCCTGGGCCA 3'
-20 -10 A A L-.CLONED ERCC-1 cDNA
CAP
Figure 3. Genomic sequence upstream of ERCC-1 exon I.
The 5 border of the cloned ERCC-1 cDNA (8) is indicated. Trans-
criptional start site(s) (as determined in Fig. 4) are shown by
triangles. Tandem sequence TGCTCTA and the 3 times repeated
sequence CCTCC are boxed. An 'abbreviated' CAAT box at -100 is
indicated by a dashed line. The pyrimidine rich stretch of
nucleotides and the HinfI site used for promoter construct
pUCPROMHI (Fig. 4) are underlined.
CAAT-box consensus sequence GGTCAATCT can be found (see Figure
3). At position -30 the sequence TCTATGC very remotely resembles
the TATATAT consensus. Several other sequence motifs are present
in the ERCC-1 promoter region. At position -20 to -30 a tandem
repeat of TGCTCTA is located. Further downstream the
pentanucleotide CCTCC occurs three times with intervals of 5
nucleotides (see Figure 3). This region (-65 to -100) is very
rich in pyrimidine residues (78%). The most upstream CCTCC motif
is part of a stretch of 13 pyrimidines.
To verify whether this region can drive ERCC-1 transcription
two genomic fragments (a 1.3 kb PvuII-StuI and 180 bp HinfI-StuI
fragment) were constructed in front of the ERCC-1 cDNA yielding
pROM-l and pUCPROMHI respectively (see Figure 4 and Materials and
Methods). These DNA constructs were transfected to 43-3B cells in
coprecipitate with the dominant vector pSV3gptH. Transformants
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Figure 4. Analysis of ERCC-1 transcriptional start site.
A two kb BglII-Pst fragment of genomic ERCC-1 subclone p56-4
(harboring32exon I and II) was subcloned in M413-mp8. Single
stranded P-labeled DNA of this fragment was annealed to K562
poly(A)+RNA and treated with nuclease Si (4000U, 1 hr, 160C).
Protected fragments (shown by arrows) were visualized by
polyacrylamide gelelectrophoresis and autoradiography. A Maxam-
Gilbert sequence ladder of an exon I fragment labeled at the StuI
site was used as a molecular weight marker. After incubation of
the probe with yeast tRNA no protected fragments were observed
(not shown). DNA fragments 1 and 2 are genomic PvuII-StuI and
HinfI-StuI fragments that were used for constructing pROM-i and
pUCPROMH-1 respectively (see Table 1).
were selected with mycophenolic acid for expression of the E.coli
qp gene and with MM-C for ERCC-1 expression.
The results summarized in Table 1 show that both ERCC-1 plasmids
can confer MM-C resistance to 43-3B cells with an efficiency
comparable to the genomic ERCC-1 gene on cosmid 43-34. This
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Table 1.
Transfected DNAs are described in Materials and Methods.
Number of mpa and MM-C
Transfected DNA resistant clones<pg
transfected DNAa)
cos43-34 (genomic ERCC-1) 25
pcDE (cDNA + SV40 early promoter) 5
pROM-1 (cDNA + 1.3 kb promoter fragment) 22
pUCPROMH-l (cDNA + 170 bp promoter fragment) 32
pROM-2 (inactivated ERCC-1 cDNA) 0
IpERCC-SVP (cDNA without promoter) 2
a) average of three dishes
Identification of the ERCC-1 promoter region. ERCC-1 promoter
activity was determined by scoring the number of mitomycin-C
and mycophenolic acid (mpa) resistant clones after
cotransfection of ERCC-1 DNA and pSV3gptH to 43-3B cells.
indicates that the two genomic regions tested display promoter
activity and confines the ERCC-1 promoter to a stretch of 170 bp
upstream of the transcriptional start site. Surprisingly, with
pcDE, harboring ERCC-1 cDNA under the direction of the strong
SV40 early promoter, always a lower transfection frequency is
observed. No repair-proficient transformants are obtained with a
non-functional ERCC-1 construct (pROM-2). However, a very low but
consistent transfection frequency is found with pERCC-SVP which
is lacking promoter sequences. This may be explained by insertion
of the SV40 early promoter derived from cotransfected pSV3gptH or
by integration of pERCC-SVP DNA in the vicinity of endogenous
promoters in the genome of 43-3B cells.
Northern blot analysis of different human cell lines
revealed a low ERCC-1 transcription level (8, data not shown).
To investigate whether the ERCC-1 promoter is DNA-damage
inducible, Northern blot analysis was performed on poly(A)+ RNA
from Hela cells at various periods of time after UV irradiation.
The results are presented in Figure 5. Hybridization with the
probe for the glyceraldeyde-3-phosphate dehydrogenase gene
(GAPDH; 20) included as control, indicates that approximately
equal amounts of poly(A)+ RNA are loaded in each lane. It is
evident that UV irradiation with a UV dose of 1 J/m2 did not
result in detectable changes of ERCC-1 transcription within a
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Fiqure E. Effect of UV-irradiation on ERCC-1 transcription.
Pol~( NA (20 pg) of exponentially growing UV-irradiated (1
J/m ) HeLa cells was size fractionated on 1% agarose gel and
i2ter blotting to nitrocellulose hybridized to a nick-translated
' P-labeled ERCC-1 cDNA probe. To verify that equal amounts of
RNA were loaded on the gel the filter was rehybridized with a
GAPDH probe (20).
period of 24 hours. Nor did a UV dose of 10 J/m2 or treatment of
HeLa cells with MM-C (10-8M) affect the level of ERCC-1 tran-
scription (data not shown).
The 3' region
The ERCC-1 cDNA was isolated from a human expression cDNA
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A 2 3 4
I 1~~~~~~~~~~~~~~~Ikb
pcDl A2 5' jI I I i I, I poly A 3'
pcD4A II I I polyA 3'
-- ~~~~A
ERCC-1 5 v SE B Pv PB Pv Hf P HIII HIIP 3',6.j;-i II I 6 I 3'I
gene exnX ~~ ~~~~exonX rzZ
B~~~~~~~~~~~~~~
CAGCTICCAA GGAAACCCCC AGTGTAATM TAAATCGTCC TCCCAGGCCA GGCTCCTGCTPvuII
GCTGCGCTGG TGCAGTCTCT GGGGAGGGAT TCTGGGGGTG TCACCTTCTG GTGGCCCAGGL-..o..PCDlA2
TGGGCACCTT CAGCTTTCTT TAGTTCCTCA GTTTCCCGGG GGCAGACTAC ACAGGCTGCT
GCTGCTGCGC EITTCCGCT TCTTGTCCCG GCCTGTGGGA GCCTCCTCCC CAGACTCTGA
L AGTGGC CGGCCCTGGC ATCTCCTCTT GGGGCACTGT CTCTGGCATC CGGCmCCTECoRI
GACTCTGCTT CTTCCTCTTC TTGGTGGATICCGGAGTTGC C--- ±1750 BP--- AGAA
GTCCAAATGT CCTAAGAATG CAGCCCCCAT TACTTAAATA TAACATAACA TAATGAGCA
JIAGGTT GCAGGATTAA TGGTCGTGGA TAACACCAAT AGCCCCTACC mAGCGAGCFIN'D 11
TTATCTGCAC ACTCCAAGTT TAACTATAGT TCCTTATAGT TTCTTATAAG TAGAAATACT
AACAAAGGGC CGTGGGTTTC TCCCCCTGCT TTCTGAGGAC ACTCTACTCT GTAAAGGAGT
AGTTTCCAALMCTTGm CTTTCACTGT GCTCTGTGAK.J-aCCTCTAA TTCTTTCCTG
TGACAMTTC AAGAACCCGC TCTTGGGGTC TGGACCGGGA CCCTCTTTTC CfiICAAAG
ACCACTCACC ATTC AAAAC AAAGTCTACA GCCAAG-3'
Fiqure 6. Detailed analysis of the 3' ERCC-1 flanking region.
A. Alignment of cDNA clones pcD4A and pcDlA2 with the genomic
region flanking the 3' site of ERCC-1 exon X. Triangles ( * )
indicate AATAAA polyadenylation signals. The dashed line
specifies fragments containing repetitive sequences as found by
Southern hybridization using human repetitive DNA as a probe (not
shown). Arrows indicate the sequence strategy and the shaded
boxes B and C are probes used for the Northern blot analysis (see
Fig. 7). Not all restriction enzyme sites are shown. Abbrevia-
tions: Pv : PvuII; S : SmaI; E EcoRI; B : BamHI; P : PstI; Hf :
HinfI; HIII : HindIII; HII : HindII. B. Composition of genomic
and cDNA sequence data. Appropriate restriction enzyme sites
shown in Fig.6A are indicated. The polyadenylation signals AATAAA
are indicated by double underlining. The boxed sequence TTC might
represent a polymorphism as it was not found in the genomic
sequence. Triangles (A) indicate polyadenylation sites as found
by sequence analysis.
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library (21) using a 3' 1.05 kb genomic PvuII fragment as a
probe. In addition to the earlier described ERCC-1 cDNA clones
(8) several other clones (pcDlA2 and pcD4A) were isolated with
this probe. As illustrated in Figure 6A the physical maps of
these clones are colinear with the genomic map of the 3' ERCC-1
flanking region. The longest clone pcDlA2 has an insert size of
approximately 2.2 kb. Furthermore, Southern blot hybridization
with human repeats as a probe revealed the presence of repetitive
sequences in both cDNA clones as well as in the corresponding
genomic fragments (not shown). The nucleotide sequence of the 5'
and 3' termini of pcDlA2 and the corresponding genomic regions of
cosmid 43-34 (7) were determined by the chemical cleavage method
of Maxam and Gilbert (13). A composition of both sequences is
presented in Figure 6B. The 3' end of pcDlA2 harbors a poly(A)
signal followed by a poly(A) tail indicating a transcriptional
orientation which is similar to that of ERCC-1. In the 5
direction clone pcD1A2 extends to 40 bp downstream of the
polyadenylation site of the 1.1 kb ERCC-1 mRNA (see Figure 6B).
This renders it conceivable that pcDlA2 is a partial cDNA clone
from a longer ERCC-1 mRNA with an alternative polyadenylation
site. To investigate this hypothesis poly(A)+ RNA of HeLa nuclei
and human primary fibroblasts was analysed by Northern blotting
using a coding ERCC-1 cDNA probe and two genomic probes of the
pcDlA2 region (see Figure 6A). The autoradiogram of this
experiment is shown in Figure 7. ERCC-1 probe 3A3 which encodes
the N-terminal half of the ERCC-1 protein recognizes the mature
1.0 - 1.1 kb ERCC-1 mRNA, a 3.4 kb transcript in fibroblasts and
a 3.4 and 3.8 kb mRNAs in HeLa nuclei. These 3.4 and 3.8 kb RNA
species are also recognized by two probes (B and C) flanking the
HindIII site in the 3' pcDlA2 region. The 3.8 kb transcript seems
to be absent in primary fibroblasts. However, although with a
much lower hybridization signal than the 3.4 band, the 3.8 kb
could be detected in poly(A)+ RNAs of a number of other cell
lines (e.g. Figure 5, data not shown). We conclude from these
results that pcD4A and pcDlA2 are partial cDNA clones derived
from the 3.4 kb ERCC-1 transcript. The 3.8 kb molecule most
likely terminates at a yet unidentified polyadenylation site
further downstream.
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Figure! 7. Northern blot analysis of ERCC-1 transcripts.
Poly(A) RNA (+ 20 jg) of HeLa nuclei and primary fibroblasts was
size fractionated by agarose gelelectrophoresis (1% agarose) 3 fnd
after blotting to nitrocellulose filters hybridized to three P-
labeled DNA probes. A: 3A3, a 5 PstI-fragment of ERCC-1 cDNA
clone pcDE (8) B and C are genomic DNA fragments (HinfI-HindIII
and HindIII-HindII respectively) from the 3' terminal region of
the ERCC-1 gene shown in Fig. 6A.
DISCUSSION
The excision repair gene ERCC-1 has been assigned to human
chromosome 19 (8,22,23) and regionally mapped to 19ql3.2-13.3
(24). Here we report the structural organization of the ERCC-1
gene. The gene is about 15 kb in length and harbors 10 exons. We
have recently shown that the coding exon VIII of 72 bp is subject
to alternative splicing. Only the cDNA of the larger ERCC-1
transcript (which includes exon VIII) inserted in a mammalian
expression vector can correct the excision repair mutation in 43-
3B cells (8). During pre-mRNA processing excision of introns
requires branchpoint formation at a distance of -40 to -20 bp
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from the 5' exon borders. The consensus sequence PyNPyTPuAPy has
been proposed for this branchpoint region (19,25,26). In contrast
to yeast where a strict requirement for the heptamer TACTAAC has
been observed (27) the sequence constraints for higher eukaryotes
seemn to be much more relaxed. Deletion or mutation of the
branchpoint region can lead to branch formation at other criptic
positions close by (19). It should be noted that except for exon
VIII all ERCC-1 3' intron junctions contain putative branchpoint
motifs matching with the consensus PyNPyTPuAPy (Figure 2). The
sequence proximal to exon VIII that most closely resembles the
branchpoint consensus has a C-residue at the conserved T-
position. Only in a few cases the presence of a C-residue at this
position of the predicted branchpoint has been observed (18).
Therefore, it is possible that the exon VIII branchpoint sequence
is less efficiently utilized during RNA processing. Since the 3
intron junction with ERCC-1 exon IX is located only 0.3 kb
downstream it is conceivable that occasionally the branchpoint
signal of exon VIII is skipped as a result of which the
alternative splicing of this exon can occur. Analysis of a number
of mouse ERCC-1 cDNA clones (manuscript in preparation) have not
given any evidence for differential RNA procesing in mouse brain
and testes tissue. It is therefore not excluded that the observed
alternative splicing of ERCC-1 mRNA is the result of an
inaccurate splicing event in human cells rather than a means to
provide additional biological functions to the ERCC-1 protein.
Using a functional assay we have shown that the ERCC-1
promoter is located in a stretch of 170 bp proximal to the
transcriptional start site. In this region there is no clear cut
TATA box or AT-rich region which is typically positioned between
-20 and -30 from the CAP-site (17). An 'abbreviated' version of a
CAAT-box might be located at -100. The apparent absence of these
promoter motifs is frequently found in housekeeping genes that
are driven by promoters containing the transcription factor Spl
binding box GGGCGG (28). The ERCC-1 promoter is also devoid of
such GC-boxes. The absence of classical transcription elements
like CAAT, TATA and GC-boxes has recently been reported for the
weakly expressed c-mos proto-oncogene (29) and is exceptional for
eukaryotic genes. Therefore, it is possible that the ERCC-1
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promoter represents a specific class of promoters. Several other
sequence motifs, of which the significance is still unknown, have
been notified in the ERCC-1 promoter region (Figure 3). Three
CCTCC repeats are located in a pyrimidine rich region from -65 to
-100. The promoter of the EGF-receptor gene harbors pyrimidine
rich stretches of nucleotides with 4 times repeated TCC elements
(30). These regions might have a regulatory function in EGF-
receptor expression since nuclear proteins were found to bind to
the TCC-containing regions (31). Possibly, ERCC-1 expression is
mediated through a similar type of interaction between regulatory
proteins and the CT-rich promoter elements.
We have not quantitatively determined the transcription
activity of the ERCC-1 gene. However, qualitative observations
from Northern blot analysis of poly(A)+ RNA of different cell
lines indicate low levels of ERCC-1 mRNA. Low constitutive
expression of repair proteins has also been observed in E.coli
and yeast (1,32). In bacteria an efficient removal of DNA lesions
is provided by an excision repair system that is part of the DNA-
damage inducible SOS-response. In yeast, the agents that elicit
this response induce the excision repair gene RAD2 whereas
transcription of RAD1, RAD3 and RAD10 is not affected by DNA-
damage (33). From our experiments it can be inferred that ERCC-1
expression is not influenced by UV or MM-C induced DNA damage.
Several observations suggest very low levels of intracel-
lular ERCC-1 protein. Firstly, as mentioned before, ERCC-1
transcripts belong to a class of low abundant mRNAs in a variety
of human cell lines (8, results not shown). Secondly, the AUG
start codon of the ERCC-1 protein lies in a very unfavourable se-
quence context (TCCAGATGG) for translation initiation (34)
because of the presence of a pyrimidine at position -3. More than
95% of eukaryotic mRNAs examined have an A (75%) or a G-residue
(20%) at that position and the consensus sequence CCACCATGG that
emerged from a compilation of the mRNA initiation sites used by
higher eukaryotes completely matched the most optimal
translational start context as found by mutation analysis
(35,36). In those studies the presence of a T at -3, as found in
ERCC-1 mRNA, caused a 10-20 fold drop in the efficiency of
translation initiation. Hence, the presence of a pyrimidine at
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position -3 of the ERCC-1 mRNA suggests a low constitutive level
of ERCC-1 translation.
The transfection efficiency of ERCC-1 constructs seems to be
promoter dependent (Table 1), since the strong SV40 promoter
yields less transformants than the weak ERCC-1 promoter. Further
experiments are required to study the effect of the ERCC-1
expression level, however the preliminary data presented in Table
1 suggest that overexpression of ERCC-1 can be deleterious to the
cell and that mimimum amounts of ERCC-1 protein are required for
repair of DNA damages.
ERCC-1 mRNA molecules of 1.1, 3.4 and 3.8 kb have been
identified by Northern blot analysis using coding ERCC-1 cDNA
probes. The 1.1 kb transcript which is the major mRNA species
encodes the protein that corrects the 43-3B mutation and harbors
all exons shown in Figure 1. Although no full length cDNA clones
have been isolated of the longer transcripts, there is strong
evidence that differential polyadenylation gives rise to the 3.4
and 3.8 kb mRNAs: i. Both transcripts are recognized by 5' ERCC-1
cDNA probes. ii. Genomic probes located approximately 2 kb 3' of
the 1.1 kb mRNA polyadenylation site hybridize with the 3.4 and
3.8 kb molecules. iii. cDNA clones of the 3.4 kb mRNA have the
ERCC-1 transcriptional orientation and have a poly(A) tail
preceeded by the polyadenylation signal AATAAA. These cDNA clones
contain human repetitive sequences and are completely colinear
with the genomic DNA as shown by restriction enzyme and partial
sequence analysis. iv. Recently, functional mouse ERCC-1 cDNA
clones have been isolated with different 3 untranslated regions
due to alternative polyadenylation (van Duin, in preparation).
In addition to the hexanucleotide AATAAA several other
loosely conserved sequence elements have been suggested to play a
role in mRNA 3' end formation (see 37 for a review). The
pentanucleotide CAYTG is found 3' of the AATAAA before or after
the poly(A) site in many genes and is suggested to mediate
poly(A) formation through interaction with RNA of the U4 small
ribonucleoprotein (38). Furthermore, T-rich and GT-rich sequences
motifs are located downstream of poly(A) sites in many
transcripts (37). Recent studies of Gil and Proudfoot (39) and
McDevitt et al. (40) have demonstrated that these motifs function
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synergistically and are important for efficient and accurate 3'
end formation. Inspection of the 3' ERCC-1 sequence revealed the
presence of CAYTG box and a T-rich element near the second AATAAA
suggesting that this can be a better target for 3' end processing
than the more proximal AATAAA.
Multiple polyadenylation sites occurring in 3' untranslated
regions have been reported for a number of transcripts
(41,42,43). It is unknown whether the selection of poly(A) sites
within one transcriptional unit is a regulatory event. In this
respect it is interesting to note that 3' untranslated sequences
of several transiently expressed genes have been implicated in
mRNA stability and that recently AU-rich sequences with AUUUA
motifs have been identified defining mRNA instability (44,45).
Deletion of such sequences from the c-fos proto-oncogene
abolishes the rapid turnover of c-fos transcripts (46) and
confers a transforming potential to the gene (47). Such elements
have not been found in the partially sequenced 3' ERCC-1 flanking
region. However, the apparent evolutionary conservation of
differential polyadenylation of ERCC-1 transcripts could imply
that mRNA 3' end processing plays a regulatory role in ERCC-1
expression.
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